drugset / Trial / NCT00149539
Abuse Potential of Buprenorphine/Naloxone
Phase 2
Terminated
12 enrolled
National Institute on Drug Abuse (NIDA)
Johns Hopkins University · collab
RandomizedCrossoverDouble-blindTreatment
Summary
Buprenorphine is a treatment for opioid dependence. Naloxone is given in addition to buprenorphine in order to limit the abuse potential that is commonly associated with buprenorphine. The purpose of this study is to determine the abuse potential of high doses of buprenorphine/naloxone in opioid dependent individuals.
Timeline
- Start
- 2004-06
- Primary completion
- —
- Completion
- 2006-01
Outcome
Outcome not reported
Stopped (Business): “Funding ended for the study”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | — | Other |
| Subject | Naloxone | Small molecule | — | Other |